Found: 17
Select item for more details and to access through your institution.
Association Between Changes in CMS Reimbursement Policy and Drug Labels for Erythrocyte-Stimulating Agents With Outcomes for Older Patients Undergoing Hemodialysis Covered by Fee-for-Service Medicare.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Sex and risk of hip implant failure: assessing total hip arthroplasty outcomes in the United States.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Sex and Risk of Hip Implant Failure.
- Published in:
- JAMA Internal Medicine, 2013, v. 173, n. 6, p. 435, doi. 10.1001/jamainternmed.2013.3271
- By:
- Publication type:
- Article
When to Start Therapy.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Mortality in HIV-Seropositive versus -Seronegative Persons in the Era of Highly Active Antiretroviral Therapy: Implications for When to Initiate Therapy.
- Published in:
- Journal of Infectious Diseases, 2004, v. 190, n. 6, p. 1046, doi. 10.1086/422848
- By:
- Publication type:
- Article
Independent Study Module for Lactation Consultants: “Maternal and Breast Pump Factors Associated with Breast Pump Problems and Injuries”.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Maternal and Breast Pump Factors Associated with Breast Pump Problems and Injuries.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Independent Study Module for Lactation Consultants: “Maternal and Breast Pump Factors Associated with Breast Pump Problems and Injuries”.
- Published in:
- 2014
- By:
- Publication type:
- Lesson Plan
Managing Cytokine Release Syndrome and Neurotoxicity with Step-Up Dosing of Mosunetuzumab in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S247, doi. 10.1016/j.clml.2019.07.151
- By:
- Publication type:
- Article
When to start antiretroviral therapy.
- Published in:
- Current HIV/AIDS Reports, 2006, v. 3, n. 2, p. 66, doi. 10.1007/s11904-006-0020-3
- By:
- Publication type:
- Article
Use of real‐world evidence in regulatory decisions for rare diseases in the United States—Current status and future directions.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 10, p. 1213, doi. 10.1002/pds.4962
- By:
- Publication type:
- Article
Response to Consumer Healthcare Products Association letter to 'Trend in rates of acetaminophen-related adverse events in the United States'.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2017, v. 26, n. 3, p. 355, doi. 10.1002/pds.4172
- By:
- Publication type:
- Article
Trends in rates of acetaminophen-related adverse events in the United States.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2016, v. 25, n. 5, p. 590, doi. 10.1002/pds.3906
- By:
- Publication type:
- Article
Reports to FDA of fatal anaphylaxis associated with intravenous iron products.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 12, p. E496, doi. 10.1002/ajh.24531
- By:
- Publication type:
- Article
Pharmacokinetics of olverembatinib (HQP1351) in the presence of a strong CYP3A4 inhibitor (itraconazole) or inducer (rifampin) in healthy volunteers.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 9, p. 1, doi. 10.1111/cts.70021
- By:
- Publication type:
- Article
Risk of Anaphylaxis With Intravenous Iron Products: In Reply.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor